QuantumDx QuantuMDx Developing Point-of-Care Multiplex System, Syndromic Panels for European Launch Premium The firm expects that next year it will launch the final version of a battery-powered instrument that can perform high-level multiplexing and provide test results in 30 minutes. QuantumDx Gets CE Mark for Rapid Point-of-Care PCR System The system will launch this week with a SARS-CoV-2 test, but the firm expects to expand its menu to include multiplex syndromic assays. CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well. QuantuMDx Raises $15.1M to Support Scale Up of Point-of-Care Molecular Diagnostic System The firm's CEO said that its MDx system is available for research use and going through CE-IVD marking ahead of its full commercial launch. QuantuMDx Receives CE-IVD Marking for SARS-CoV-2 Test The company said it has scaled up production capacity to two million reactions per week and has the potential to scale up to three million reactions per week. Feb 12, 2020 Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus Premium Jan 27, 2020 QuantuMDx Raises $14M to Support Development of POC Genotyping Assay Dec 10, 2019 Ontera, QuantuMDx Partner on Sepsis Test Development Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Feb 21, 2019 With Studies Underway in South America and Asia, QuantuMDx Readies POC Platform for Launch Premium Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Jan 24, 2018 QuantuMDx Raises $12M Feb 2, 2017 QuantuMDx, Global Good Partner on POC Cervical Cancer Screening in Low-Resource Settings Premium Nov 28, 2016 QuantuMDx Wins Gates Foundation Funds for Point-of-Care TB MDx Premium Jun 9, 2015 QuantuMDx, Scienion Partner to Commercialize Nanowire Biosensor Oct 28, 2014 IP Roundup: CalTech, QuantumDx, Fluidigm Win US Patents Premium Oct 28, 2014 FIND Collaborates with Multiple Firms on MDx Tests for TB Sep 16, 2014 With Handheld Test Device Prototype Ready, QuantuMDx Seeks Financing to Support Commercial Launch Premium Jul 1, 2014 People in the News: John Burn, Andrzej Jakubowiak, Shaji Kumar, Sagnar Lonial, Gareth Morgan, Antonio Palumbo, and Others Premium Jun 10, 2014 QuantuMDx to Invest in Molecular Diagnostics Pipeline, R&D Teams Following $8.4M Funding Round Premium Jun 2, 2014 QuantuMDx Raises $8.4M to Support Development of POC MDx Device Apr 2, 2014 QuantuMDx, Singapore Institute Reach Microfluidics Technology Agreement Jan 27, 2014 QuantuMDx Eyeing 2015 Launch of Handheld POC MDx Device Jan 8, 2014 People in the News: Elaine Warburton: Jan 8, 2014 Premium Jan 8, 2014 People in the News: Elaine Warburton: Jan 8, 2014 (rev. 1) Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.